DIAGNOSIS CODES FOR COVID-19 ANTIBODY TESTING Report code Z01. 84, “Encounter for antibody response examination,” if the antibody test is neither to confirm a current COVID-19 infection nor for follow-up of a known infection.
ICD-10 code R76. 0 for Raised antibody titer is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
9.
Encounter for screening for other metabolic disorders The 2022 edition of ICD-10-CM Z13. 228 became effective on October 1, 2021.
R76. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R76. 0 became effective on October 1, 2021.
Antibody titer is a laboratory test that measures the level of antibodies in a blood sample.
PREVENTIVE SCREENING CODE CROSSWALKPreventive screeningICD-9 codesICD-10 equivalentsLipoid disorder screeningV77.91 Screening for lipoid disordersZ13.220 Encounter for screening for lipoid disorders11 more rows
Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Z12.11. Encounter for screening for malignant neoplasm of colon.
Indications for a CBC generally include the evaluation of bone marrow dysfunction as a result of neoplasms, therapeutic agents, exposure to toxic substances, or pregnancy.
Abnormal finding of blood chemistry, unspecified R79. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R79. 9 became effective on October 1, 2021.
Coding Guidelines: Currently, CRP (CPT code 86140) is covered as a diagnostic test for the detection and evaluation of infection, tissue injury and inflammatory disease, not involving atherosclerosis of the arteries.